Trends in the treatment of uterine leiomyosarcoma in the Medicare population.

Foley, Olivia W; Rauh-Hain, J Alejandro; Clemmer, Joel; Clark, Rachel M; Hall, Tracilyn; Diver, Elisabeth J; Schorge, John O; del Carmen, Marcela G

Foley, Olivia W; Rauh-Hain, J Alejandro; Clemmer, Joel; Clark, Rachel M; Hall, Tracilyn; Diver, Elisabeth J; Schorge, John O; del Carmen, Marcela G.

Affiliation

Foley OW; Division of Gynecologic Oncology, Vincent Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.

Int J Gynecol Cancer ; 25(3): 453-8, 2015 Mar.

Article in En | MEDLINE | ID: mdl-25628107

Subject(s)

Chemotherapy, Adjuvant/trends; Leiomyosarcoma/therapy; Radiotherapy, Adjuvant/trends; Uterine Neoplasms/therapy; Age Factors; Aged; Antineoplastic Agents/therapeutic use; Female; Health Status; Humans; Leiomyosarcoma/pathology; Medicare/trends; Neoplasm Staging; SEER Program; Survival Rate; United States; Uterine Neoplasms/pathology

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Uterine Neoplasms / Chemotherapy, Adjuvant / Radiotherapy, Adjuvant / Leiomyosarcoma Type of study: Prognostic_studies / Screening_studies Limits: Aged / Female / Humans Country/Region as subject: America do norte Language: En Journal: Int J Gynecol Cancer Journal subject: GINECOLOGIA / NEOPLASIAS Year: 2015 Type: Article Affiliation country: Morocco

Fulltext

XML

PubMed Links

Search on Google